Provided by Tiger Trade Technology Pte. Ltd.

Mersana Therapeutics Inc.

29.08
0.0000
Volume:- -
Turnover:20.77M
Market Cap:145.36M
PE:-2.06
High:29.08
Open:29.08
Low:29.08
Close:29.08
52wk High:36.25
52wk Low:5.21
Shares:5.00M
Float Shares:3.75M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0861
EPS(LYR):-14.1163
ROE:-505.14%
ROA:-36.27%
PB:-2.44
PE(LYR):-2.06

Loading ...

Mersana Therapeutics Inc : Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
Nov 13, 2025

Mersana Therapeutics Inc : Wedbush Cuts Neutral From Outperform; Raises Target Price to $27.25 From $13

THOMSON REUTERS
·
Nov 13, 2025

Day One to Buy Mersana Therapeutics for Up to $285 Million

Dow Jones
·
Nov 13, 2025

Mersana Therapeutics Shares Climb 206% Premarket After Co to Be Acquired by Day One Biopharmaceuticals

THOMSON REUTERS
·
Nov 13, 2025

Mersana Therapeutics Inc Proposed Deal for $25.00 per Share in Cash

THOMSON REUTERS
·
Nov 13, 2025

Mersana Therapeutics Inc - Day One to Buy Mersana for up to $285 Mln

THOMSON REUTERS
·
Nov 13, 2025

Day One Biopharmaceuticals to Acquire Mersana Therapeutics

THOMSON REUTERS
·
Nov 13, 2025

Mersana Therapeutics Inc. to Report Third Quarter 2025 Results

Reuters
·
Nov 10, 2025

Mersana Therapeutics Inc expected to post a loss of $1.61 a share - Earnings Preview

Reuters
·
Nov 07, 2025

Mersana Therapeutics Inc. Receives Nasdaq Notice for Non-Compliance with Market Value Listing Rule

Reuters
·
Sep 06, 2025

Mersana Therapeutics Inc : Truist Securities Adjusts Target Price to $36 From $250 to Reflect 1-for-25 Reverse Stock Split

THOMSON REUTERS
·
Aug 14, 2025

U.S. RESEARCH ROUNDUP-Air Products, Biogen and JLL

Reuters
·
Aug 14, 2025

Mersana Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13, 2025

Rpt- Mersana Therapeutics Q2 EPS $-4.87

THOMSON REUTERS
·
Aug 13, 2025

Mersana Therapeutics Inc expected to post a loss of $3.93 a share - Earnings Preview

Reuters
·
Aug 08, 2025

Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025

GlobeNewswire
·
Aug 06, 2025

Mersana Therapeutics Announces 1-for-25 Reverse Stock Split Effective July 25, 2025

Reuters
·
Jul 24, 2025

Mersana Therapeutics Inc - Stockholders to Receive Cash in Lieu of Fractional Shares

THOMSON REUTERS
·
Jul 24, 2025